Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The NADPH oxidase complex is a membrane-bound, multi-protein enzyme complex responsible for generating superoxide, a reactive oxygen species essential for immune cell microbial killing and various redox-dependent cellular functions[1][3][4][5][6][7]. It consists of a catalytic core (NOX isoforms such as NOX2/gp91^phox^) complexed with regulatory subunits (including p22^phox^, p47^phox^, p67^phox^, and Rac GTPase) whose assembly at the membrane is tightly regulated and necessary for enzymatic activity[1][2][3][7]. Impaired complex assembly/function underlies disorders like chronic granulomatous disease, while excessive or dysregulated ROS production contributes to cardiovascular, inflammatory, and neurodegenerative diseases[1][7]. Restoration of NADPH oxidase complex assembly/function is thus both a concept for treating immunodeficiency and a target for inhibiting pathological ROS production in non-infectious diseases[1][4][7].
Inhibition of electron transfer through NOX catalytic core Disruption of complex assembly (inhibiting cytosolic subunit recruitment) Scavenging of ROS (indirect downstream effect)
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on NADPH oxidase complex (NOX complex).